Patients with type 2 diabetes not achieving glycemic targets on OADs with/without basal insulin can reach HbA1c targets with biphasic insulin aspart 30/70

被引：0
|
作者：
Jain, R
Braceras, R
Wahl, T
Wahlen, J
Bressler, P
Deng, L
Garber, A
机构：
[1] Milwaukee Med Clin, Milwaukee, WI USA
[2] Novo Nordisk Inc, Clin Dev Regulatory & Med Affairs, Princeton, NJ USA
[3] Internal Med Associates, Omaha, NE USA
[4] Endocrine Res Specialists, Ogden, UT USA
[5] Endocrine & Diabet Associates, Dallas, TX USA
[6] Baylor Coll Med, Houston, TX 77030 USA
来源：
DIABETOLOGIA | 2005年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
837
引用
收藏
页码：A304 / A304
页数：1
相关论文
共 50 条
  • [1] Efficacy of biphasic insulin aspart 70/30 in patients with T2DM not achieving glycemic targets on OADs with/without basal insulin therapy
    Jain, R
    Allen, E
    Wahl, T
    Wahlen, J
    Bressler, P
    Deng, L
    Garber, A
    [J]. DIABETES, 2005, 54 : A69 - A69
  • [2] Efficacy of biphasic insulin aspart 70/30 in insulin-naive patients with type 2 diabetes mellitus not achieving glycemic targets on oral antidiabetic agents
    Garber, Alan J.
    Jain, Rajeev
    Wahl, Timothy
    Moses, Alan
    Cao, Anjun
    Bressler, Peter
    [J]. DIABETES, 2006, 55 : A477 - A477
  • [3] Patients with type 2 diabetes can achieve A1C targets with once-daily biphasic insulin aspart 70/30 before supper
    Jain, R
    Wahl, T
    Wahlen, J
    Bressler, P
    Hu, P
    Allen, E
    [J]. DIABETES, 2004, 53 : A130 - A130
  • [4] Comparison of the cost to reach A1C targets in patients with type-2 diabetes mellitus on oral antidiabetic agents and either biphasic insulin aspart 70/30 or insulin glargine
    Cobden, D
    Allen, E
    Botteman, M
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 358 - 358
  • [5] The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting
    Meneghini, Luigi F.
    Mauricio, Didac
    Orsi, Emanuela
    Lalic, Nebojsa M.
    Cali, Anna M. G.
    Westerbacka, Jukka
    Stella, Peter
    Candelas, Christophe
    Pilorget, Valerie
    Perfetti, Riccardo
    Khunti, Kamlesh
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (06): : 1429 - 1436
  • [6] Achieving HbA1c targets in patients initiated on insulin - a retrospective audit
    Mettayil, J.
    Kakarla, R.
    Sanders, E.
    [J]. DIABETIC MEDICINE, 2007, 24 : 119 - 119
  • [7] Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
    Valensi, Paul
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY, 2009, 2 : 61 - 71
  • [8] Predictors of achieving HbA1c <7% and no hypoglycaemia 6 months after initiation of biphasic insulin aspart 30 in patients with type 2 diabetes in the IMPROVE study
    Valensi, Paul
    Shaban, Joseph
    Benroubi, Marian
    Kawamori, Ryuzo
    Borzi, Vito
    Shah, Siddharth
    Yang Wenying
    Prusty, Vinay
    Hansen, Jes B.
    Gumprecht, Janusz
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (06) : 601 - 609
  • [9] Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets
    Dalal, Mehul R.
    Grabner, Michael
    Bonine, Nicole
    Stephenson, Judith J.
    DiGenio, Andres
    Bieszk, Nella
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 121 : 17 - 26
  • [10] Multiple HbA1c targets and insulin analogues in type 2 diabetes: a systematic review
    Giugliano, Dario
    Maiorino, Maria Ida
    Bellastella, Giuseppe
    Chiodini, Paolo
    Esposito, Katherine
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2011, 25 (04) : 275 - 281
12345